P.A.R.T. Texas is committed to protecting access to safe, individualized chronic pain treatment. Below are our current advocacy statements, upcoming bills, policy positions, and press releases.
Watch: P.A.R.T. Texas June 2026 Advocacy Update — Texas Medical Board, Washington, D.C., and Texas GOP State Convention
P.A.R.T. Texas made major advocacy impacts in June 2026, including work connected to the Texas Medical Board, Washington, D.C. advocacy efforts, and the Texas GOP State Convention. This update explains how P.A.R.T. Texas is continuing to push for chronic pain patients, medical freedom, access to care, and meaningful policy change.
Watch: Texas Medical Board Major Update — Recorded June 12, 2026
Texas Chronic Pain Resolution – Precinct Convention (2026)
This resolution addressing the challenges faced by chronic pain patients was introduced and passed at a Texas precinct convention. It advanced to the Senatorial District Convention on March 28, 2026, where it passed in three separate districts. The resolution is now moving forward to the State Convention, being held in Houston by the Texas GOP on June 11-13, 2026.
Status: Passed at Precinct Convention – Passed at Senatorial District Convention in Three Locations – Advancing to State Convention
Click the image to view the full resolution
-
Awareness matters — but protection is what stops forced tapers and retaliation in real time. This statement explains the difference between pressure strategies and enforceable protection strategies, and why P.A.R.T. is structured to build laws that work.
P.A.R.T. Texas reviews pain policy legislation across the United States, separating facts from misinformation and explaining what these laws actually mean for chronic pain patients.
Series: Pain Policy Watch – State by State
Break the Bottleneck Act
A Texas-based proposal to address artificial drug shortages by supporting intrastate pharmaceutical manufacturing and restoring state authority over medical supply systems.
Watch: How This Bill Restores Access to Care
Policy
Coming soon.